Drug Type Chemical drugs |
Synonyms XAV 939 |
Target |
Action stimulants, inhibitors |
Mechanism AXIN1 stimulants(axin 1 stimulants), TNKS1 inhibitors(tankyrase inhibitors), TNKS2 inhibitors(tankyrase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H11F3N2OS |
InChIKeyKLGQSVMIPOVQAX-UHFFFAOYSA-N |
CAS Registry284028-89-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | China | 30 Sep 2009 | |
Neoplasms | Preclinical | Germany | 30 Sep 2009 |